Danner S - Search Results

1

Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivo.

Nijhuis M, Schuurman R, de Jong D, van Leeuwen R, Lange J, Danner S, Keulen W, de Groot T, Boucher CA. Nijhuis M, et al. Among authors: danner s. J Infect Dis. 1997 Aug;176(2):398-405. doi: 10.1086/514056. J Infect Dis. 1997. PMID: 9237704

2

Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

Schuurman R, Nijhuis M, van Leeuwen R, Schipper P, de Jong D, Collis P, Danner SA, Mulder J, Loveday C, Christopherson C, et al. Schuurman R, et al. Among authors: danner sa. J Infect Dis. 1995 Jun;171(6):1411-9. doi: 10.1093/infdis/171.6.1411. J Infect Dis. 1995. PMID: 7539472

3

Additive or sequential nucleoside analogue therapy compared with continued zidovudine monotherapy in human immunodeficiency virus-infected patients with advanced disease does not prolong survival: an observational study.

van Leeuwen R, Bonsel GJ, Reiss P, Danner SA, Lange JM. van Leeuwen R, et al. Among authors: danner sa. J Infect Dis. 1997 Jun;175(6):1344-51. doi: 10.1086/516466. J Infect Dis. 1997. PMID: 9180173 Clinical Trial.

4

Results of long-term follow-up of HIV-infected patients treated with lamivudine monotherapy, followed by a combination of lamivudine and zidovudine.

van Leeuwen R, Lange JM, Nijhuis M, Schuurman R, Reiss P, Danner SA, Boucher CA. van Leeuwen R, et al. Among authors: danner sa. Antivir Ther. 1997 Apr;2(2):79-90. Antivir Ther. 1997. PMID: 11322279

5

Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis.

Koot M, van Leeuwen R, de Goede RE, Keet IP, Danner S, Eeftinck Schattenkerk JK, Reiss P, Tersmette M, Lange JM, Schuitemaker H. Koot M, et al. Among authors: danner s. J Infect Dis. 1999 Jan;179(1):254-8. doi: 10.1086/314539. J Infect Dis. 1999. PMID: 9841850

6

Failure of zidovudine prophylaxis after accidental exposure to HIV-1.

Lange JM, Boucher CA, Hollak CE, Wiltink EH, Reiss P, van Royen EA, Roos M, Danner SA, Goudsmit J. Lange JM, et al. Among authors: danner sa. N Engl J Med. 1990 May 10;322(19):1375-7. doi: 10.1056/NEJM199005103221907. N Engl J Med. 1990. PMID: 2325735 Free article. No abstract available.

7

High-dose interferon-alpha2a exerts potent activity against human immunodeficiency virus type 1 not associated with antitumor activity in subjects with Kaposi's sarcoma.

Frissen PH, de Wolf F, Reiss P, Bakker PJ, Veenhof CH, Danner SA, Goudsmit J, Lange JM. Frissen PH, et al. Among authors: danner sa. J Infect Dis. 1997 Sep;176(3):811-4. doi: 10.1086/517309. J Infect Dis. 1997. PMID: 9291341

8

Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively.

van't Wout AB, Ran LJ, de Jong MD, Bakker M, van Leeuwen R, Notermans DW, Loeliger AE, de Wolf F, Danner SA, Reiss P, Boucher CA, Lange JM, Schuitemaker H. van't Wout AB, et al. Among authors: danner sa. J Clin Invest. 1997 Nov 1;100(9):2325-32. doi: 10.1172/JCI119771. J Clin Invest. 1997. PMID: 9410911 Free PMC article.

9

Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons.

Wit FW, van Leeuwen R, Weverling GJ, Jurriaans S, Nauta K, Steingrover R, Schuijtemaker J, Eyssen X, Fortuin D, Weeda M, de Wolf F, Reiss P, Danner SA, Lange JM. Wit FW, et al. Among authors: danner sa. J Infect Dis. 1999 Apr;179(4):790-8. doi: 10.1086/314675. J Infect Dis. 1999. PMID: 10068573

10

Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy.

Pontesilli O, Kerkhof-Garde S, Notermans DW, Foudraine NA, Roos MT, Klein MR, Danner SA, Lange JM, Miedema F. Pontesilli O, et al. Among authors: danner sa. J Infect Dis. 1999 Jul;180(1):76-86. doi: 10.1086/314837. J Infect Dis. 1999. PMID: 10353864 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters